These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9765932)

  • 21. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
    Urlacher VB; Schmid RD
    Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
    [No Abstract]   [Full Text] [Related]  

  • 22. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flavocytochrome P-450 BM3: a paradigm for the analysis of electron transfer and its control in the P-450s.
    Munro AW; Noble MA; Miles CS; Daff SN; Green AJ; Quaroni L; Rivers S; Ost TW; Reid GA; Chapman SK
    Biochem Soc Trans; 1999 Feb; 27(2):190-6. PubMed ID: 10093732
    [No Abstract]   [Full Text] [Related]  

  • 24. Flavocytochrome P450 BM3 substrate selectivity and electron transfer in a model cytochrome P450.
    Munro AW; Noble MA; Ost TW; Green AJ; McLean KJ; Robledo L; Miles CS; Murdoch J; Chapman SK
    Subcell Biochem; 2000; 35():297-315. PubMed ID: 11192726
    [No Abstract]   [Full Text] [Related]  

  • 25. Structural and enzymological analysis of the interaction of isolated domains of cytochrome P-450 BM3.
    Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
    FEBS Lett; 1994 Apr; 343(1):70-4. PubMed ID: 8163021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
    Neeli R; Roitel O; Scrutton NS; Munro AW
    J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational re-design of the substrate binding site of flavocytochrome P450 BM3.
    Ost TW; Miles CS; Murdoch J; Cheung Y; Reid GA; Chapman SK; Munro AW
    FEBS Lett; 2000 Dec; 486(2):173-7. PubMed ID: 11113461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel inhibitor of cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):411S. PubMed ID: 8131985
    [No Abstract]   [Full Text] [Related]  

  • 29. P450 BM3: the very model of a modern flavocytochrome.
    Munro AW; Leys DG; McLean KJ; Marshall KR; Ost TW; Daff S; Miles CS; Chapman SK; Lysek DA; Moser CC; Page CC; Dutton PL
    Trends Biochem Sci; 2002 May; 27(5):250-7. PubMed ID: 12076537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox cycling by cytochrome P-450.
    Besse P; Modi S; Boyle JM; Roberts GC; Primrose WU
    Biochem Soc Trans; 1997 Nov; 25(4):S579. PubMed ID: 9450007
    [No Abstract]   [Full Text] [Related]  

  • 31. Control of electron transfer in neuronal NO synthase.
    Daff S; Noble MA; Craig DH; Rivers SL; Chapman SK; Munro AW; Fujiwara S; Rozhkova E; Sagami I; Shimizu T
    Biochem Soc Trans; 2001 May; 29(Pt 2):147-52. PubMed ID: 11356143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer.
    Munro AW; Malarkey K; McKnight J; Thomson AJ; Kelly SM; Price NC; Lindsay JG; Coggins JR; Miles JS
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):423-8. PubMed ID: 7980400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screens based on NAD(P)H depletion.
    Glieder A; Meinhold P
    Methods Mol Biol; 2003; 230():157-70. PubMed ID: 12824579
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of Thr268 in oxygen activation of cytochrome P450BM-3.
    Yeom H; Sligar SG; Li H; Poulos TL; Fulco AJ
    Biochemistry; 1995 Nov; 34(45):14733-40. PubMed ID: 7578081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of replacement of ferriprotoporphyrin IX in the haem domain of cytochrome P-450 BM-3 on substrate binding and catalytic activity.
    Modi S; Primrose WU; Lian LY; Roberts GC
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):939-43. PubMed ID: 7575430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NADPH oxidase activity of cytochrome P-450 BM3 and its constituent reductase domain.
    Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
    Biochim Biophys Acta; 1995 Oct; 1231(3):255-64. PubMed ID: 7578214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the domain structure of cytochrome P450 102 (BM-3): isolation and properties of a 45-kDa FAD/NADP domain.
    Black SD
    Biochem Biophys Res Commun; 1994 Aug; 203(1):162-8. PubMed ID: 8074651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
    Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
    FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.